Latest Clinical Laboratory Improvement Amendments Stories
iGenix today announced it has received CLIA approval for its first diagnostic assay created to run on the Illumina BeadXpress. Seattle, WA (PRWEB) July 26, 2011 iGenix today announced it has received CLIA approval for its first diagnostic assay created to run on the Illumina BeadXpress, a high-throughput genomic analysis platform manufactured by Illumina Inc.
VICTORIA, Australia, April 26, 2011 /PRNewswire/ -- Genetic Technologies Limited (ASX: GTG; NASDAQ: GENE) has gained certification of its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) (42 U.S.C.
TEMPE, Ariz., April 20, 2011 /PRNewswire/ -- Intrinsic Bioprobes Inc. ("IBI") today announced the launch of its first mass spectrometry-based protein assays for in-vitro diagnostic testing.
MILTON PARK, OXFORD, England and SAN DIEGO, April 11, 2011 /PRNewswire/ -- Enigma Diagnostics announced today that it has commenced clinical trials for its intended point of care EnigmaÂ® ML Influenza A/B detection assay. Enigma will submit its application to the U.S.
CRAIGAVON, Northern Ireland, March 30, 2011 /PRNewswire/ -- Almac's Diagnostics business unit today announced the opening of its CLIA registered laboratory. The opening of the Almac CLIA Laboratory supports the company's ongoing Biomarker Discovery and Development Strategy by enabling the use of novel tests to stratify and enrich prospective clinical trails.
ANN ARBOR, Mich. March 7, 2011 /PRNewswire/ -- Everist Genomics announced today that it has received U.S.
- The horn of a unicorn considered as a medical or pharmacological ingredient.
- A winged horse with a single horn on its head; a winged unicorn.